Episode 513: LUGANO Phase 3 Trial Results Discussion with Drs. Mohsin Ali and Katherine Talcott

Drs. Maura Di Nicola and Basil Williams join to discuss the September 2026 edition of Retinal Physician found online at http://www.retinalphysician.com. Topics focus on ocular oncology and uveitis.

Drs. Mohsin Ali and Katherine Talcott join to discuss the LUGANO Phase 3 Trial results, which examined vorolanib in the treatment of wet age-related macular degeneration.

Dr. Sabin Dang joins to discuss multiple business of retina topics including intravitreal drug pricing in the face of tariffs in the United States, 340b drug pricing changes, and more.

Drs. Akshay Thomas and Sarwar Zahid join for a journal club discussion of three recent articles in the ophthalmology literature. Retinal Laser Prophylaxis for Lattice Degeneration (https://www.ophthalmologyretina.org/article/S2468-6530(26)00308-8/abstract) Anti-VEGF Access Medicare Advantage versus Fee-for-service (https://www.aaojournal.org/article/S0161-6420(26)00453-7/abstract) Conversion to Wet Macular Degeneration after Cataract Surgery (https://www.aaojournal.org/article/S0161-6420(26)00420-3/abstract)

Drs. Avni Finn and Matthew Starr join to discuss their favorite presentations and topics from the 2026 ASRS Annual Meeting.

Dr. Daraius Shroff joins the podcast to discuss several topics including differences between the US and India in training for retinal surgeons, AMT for management of recalcitrant macular holes, and PEHCR treatment. 

Drs. Kat Talcott and Akshay Thomas join for a journal club podcast discussion:‍‍Mark Cuban Cost Plus Ophthalmology Medications (https://www.aaojournal.org/article/S0161-6420(26)00378-7/fulltext)Resident Continuity Clinics (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2848897)PDR Long-Term Outcomes (https://www.ophthalmologyretina.org/article/S2468-6530(26)00218-6/abstract)Marginal Outer Retinal Ridge in PDR (https://www.ophthalmologyretina.org/article/S2468-6530(26)00274-5/abstract)‍ ‍

Drs. Safa Rahmani and Kat Talcott join to preview the July 2026 of Retinal Physician found online at http://www.retinalphysician.com. Topics covered include intraocular tamponades and elevation impact on surgical decision making.

Dr. Patrick Staropoli joins the program to discuss his NASCAR career, how he has balanced it with a career in surgical retina, and his decision to take a year from retina to compete full-time on the circuit.

Drs. Jeffrey Heier and Peter Kaiser of Ocular Therapeutix join to discuss the SOL-1 trial results investigating a novel tyrosine kinase inhibitor for wet age-related macular degeneration. Conflicts of Interest: Dr. Sridhar has consulted on an advisory board in the past 24 months for Ocular Therapeutix. Dr. Heier and Dr. Kaiser are employed by Ocular Therapeutix.